S&P 500

5.487,03

0,25%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Phoenix Biotech Aquisition Corporation (PBAXU)
Phoenix Biotech Aquisition Corporation (PBAXU) Notícias

PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PBAXU

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/06/2024	18:13	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
22/05/2024	09:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
17/05/2024	18:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
16/05/2024	07:28	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
06/05/2024	18:11	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
03/05/2024	17:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
02/05/2024	01:16	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
01/05/2024	17:45	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
15/04/2024	17:36	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
03/04/2024	18:27	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
02/04/2024	08:12	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
02/04/2024	08:07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
01/04/2024	22:54	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
27/03/2024	22:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
26/02/2024	23:37	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
23/02/2024	19:13	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
20/02/2024	19:18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
16/02/2024	21:29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
14/02/2024	14:14	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
22/01/2024	19:29	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
19/07/2023	09:33	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
03/07/2023	14:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
07/06/2023	07:05	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
05/06/2023	10:27	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
12/05/2023	17:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
24/03/2023	07:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
14/02/2023	17:46	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
14/02/2023	08:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
20/12/2022	18:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
21/11/2022	10:39	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation